Literature DB >> 29951733

Author's Reply to Segura-Aguilar: Autophagosome maturation not autophagy induction is impaired in neurodegeneration.

Alan J Fowler1, Charbel E-H Moussa2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29951733     DOI： 10.1007/s40263-018-0534-4

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  11 in total

1.  Autophagy and related mechanisms of lysosome-mediated protein degradation.

Authors:  W A Dunn
Journal:  Trends Cell Biol       Date:  1994-04       Impact factor: 20.808

2.  Comment on: "Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease".

Authors:  Juan Segura-Aguilar
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 3.  Functions of lysosomes.

Authors:  C De Duve; R Wattiaux
Journal:  Annu Rev Physiol       Date:  1966       Impact factor: 19.318

Review 4.  Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.

Authors:  Alan J Fowler; Charbel E-H Moussa
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

5.  Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.

Authors:  Brian Spencer; Rewati Potkar; Margarita Trejo; Edward Rockenstein; Christina Patrick; Ryan Gindi; Anthony Adame; Tony Wyss-Coray; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

6.  Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease.

Authors:  I Lonskaya; M L Hebron; N K Algarzae; N Desforges; C E-H Moussa
Journal:  Neuroscience       Date:  2012-12-20       Impact factor: 3.590

7.  Prelysosomal convergence of autophagic and endocytic pathways.

Authors:  P B Gordon; P O Seglen
Journal:  Biochem Biophys Res Commun       Date:  1988-02-29       Impact factor: 3.575

8.  Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance.

Authors:  Michaeline L Hebron; Irina Lonskaya; Charbel E-H Moussa
Journal:  Autophagy       Date:  2013-06-19       Impact factor: 16.016

9.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

10.  Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.

Authors:  Michaeline L Hebron; Irina Lonskaya; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2013-05-10       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.